KLRS
Price
$2.50
Change
-$0.06 (-2.34%)
Updated
Jul 3 closing price
Capitalization
46.76M
VRTX
Price
$459.62
Change
+$2.59 (+0.57%)
Updated
Jul 3 closing price
Capitalization
118.03B
25 days until earnings call
Interact to see
Advertisement

KLRS vs VRTX

Header iconKLRS vs VRTX Comparison
Open Charts KLRS vs VRTXBanner chart's image
Kalaris Therapeutics
Price$2.50
Change-$0.06 (-2.34%)
Volume$35.7K
Capitalization46.76M
Vertex Pharmaceuticals
Price$459.62
Change+$2.59 (+0.57%)
Volume$763.96K
Capitalization118.03B
KLRS vs VRTX Comparison Chart in %
Loading...
KLRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KLRS vs. VRTX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KLRS is a Hold and VRTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (KLRS: $2.50 vs. VRTX: $459.62)
Brand notoriety: KLRS and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KLRS: 75% vs. VRTX: 45%
Market capitalization -- KLRS: $46.76M vs. VRTX: $118.03B
KLRS [@Biotechnology] is valued at $46.76M. VRTX’s [@Biotechnology] market capitalization is $118.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KLRS’s FA Score shows that 1 FA rating(s) are green whileVRTX’s FA Score has 1 green FA rating(s).

  • KLRS’s FA Score: 1 green, 4 red.
  • VRTX’s FA Score: 1 green, 4 red.
According to our system of comparison, VRTX is a better buy in the long-term than KLRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KLRS’s TA Score shows that 4 TA indicator(s) are bullish while VRTX’s TA Score has 4 bullish TA indicator(s).

  • KLRS’s TA Score: 4 bullish, 4 bearish.
  • VRTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VRTX is a better buy in the short-term than KLRS.

Price Growth

KLRS (@Biotechnology) experienced а -2.34% price change this week, while VRTX (@Biotechnology) price change was +3.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

KLRS is expected to report earnings on May 01, 2025.

VRTX is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRTX($118B) has a higher market cap than KLRS($46.8M). KLRS YTD gains are higher at: 495.238 vs. VRTX (14.135). VRTX has more cash in the bank: 6.2B vs. KLRS (101M).
KLRSVRTXKLRS / VRTX
Capitalization46.8M118B0%
EBITDAN/A-74.9M-
Gain YTD495.23814.1353,504%
P/E RatioN/A32.76-
RevenueN/A11.1B-
Total Cash101M6.2B2%
Total DebtN/A1.65B-
FUNDAMENTALS RATINGS
VRTX: Fundamental Ratings
VRTX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KLRSVRTX
RSI
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
63%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
60%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
62%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 4 days ago
59%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
44%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
69%
Bearish Trend 4 days ago
54%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
KLRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FINV9.840.33
+3.47%
FinVolution Group
CBIO15.890.35
+2.22%
Crescent Biopharma Inc
ATNM1.440.01
+0.70%
Actinium Pharmaceuticals
HD371.68-0.17
-0.05%
Home Depot
LEGN35.64-0.27
-0.75%
Legend Biotech Corp

KLRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KLRS has been loosely correlated with PTHS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KLRS jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLRS
1D Price
Change %
KLRS100%
-2.34%
PTHS - KLRS
44%
Loosely correlated
-1.91%
SPRO - KLRS
21%
Poorly correlated
+0.34%
VRTX - KLRS
9%
Poorly correlated
+0.57%
JBIO - KLRS
6%
Poorly correlated
+3.15%
ANRO - KLRS
5%
Poorly correlated
+2.17%
More